Alyssa’s Story
Find out more about how Cure Leukaemia's funding impacts patients in Sheffield and across the region
Cure Leukaemia is proud to play a vital role in supporting blood cancer patients across Sheffield. The Royal Hallamshire Hospital is a TAP Network affiliated hospital, which enables patients have access to pioneering treatments and potentially life-saving clinical trials.
Our support also extends to young patients and their families, with Sheffield Children’s Hospital also being an important part of the ATICUS Network – a groundbreaking initiative bringing together leading centres to deliver world-class care and research opportunities.
Together, these efforts help to provide hope, innovation, and improved outcomes for people facing blood cancer in our city.
Discover which clinical trials have been delivered in Sheffield, with support of funding from Cure Leukaemia
The VICTOR trial is a groundbreaking clinical trial available at TAP Centres across the UK, comparing a combination of two targeted drugs to traditional chemotherapy. This trial, specifically designed for AML patients aged 60 and over, offered a less toxic and more manageable treatment option.
A Phase 2 randomised trial for adults with Richter’s syndrome, a rare and aggressive form of lymphoma. The STELLAR trial is the first randomised trial for Richter’s syndrome in the UK, and it demonstrates the nation’s growing ability to run trials in rare diseases. The study also includes crucial translational research that will help tailor future therapies.
Focused on patients with Myelofibrosis, the Fedora trial is tackling a critical area of unmet need, gathering information about whether a combination of treatments is tolerated, and whether it provides a therapeutic benefit to patients. The FEDORA Trial has now completed recruitment, with results expected to be published soon.
Alyssa’s Story
Kathryn’s Story
Austin’s Story
Jude’s Story